Table 4.

Association between G protein‐coupled receptor (GPR) 30 expression and clinicopathological variables

Clinicopathological data	No. patients		GPR30 expression		P‐value
	n	%	Positive	Negative
FIGO stage
Stage I	24	48	18	6	0.119*
Stage II	10	20	7	3
Stage III	16	32	10	6
Grade
G1	10	20	5	5	0.029*
G2	26	52	18	8
G3	14	28	12	2
Myometrial invasion
≤1/2	36	72	23	13	0.863 †
>1/2	14	28	10	4
Peritoneal cytology
Negative	42	84	23	19	0.987 †
Positive	8	16	5	3

^* Binary logistic regression test.

^† χ² continuity correction test.